PT95826A - Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico

Info

Publication number
PT95826A
PT95826A PT95826A PT9582690A PT95826A PT 95826 A PT95826 A PT 95826A PT 95826 A PT95826 A PT 95826A PT 9582690 A PT9582690 A PT 9582690A PT 95826 A PT95826 A PT 95826A
Authority
PT
Portugal
Prior art keywords
alpha
liponic acid
preparation
active ingredient
pharmaceutical compositions
Prior art date
Application number
PT95826A
Other languages
English (en)
Other versions
PT95826B (pt
Inventor
Jurgen Engel
Heinz Ulrich
Carl-Heinrich Weischer
Helmut Hettche
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of PT95826A publication Critical patent/PT95826A/pt
Publication of PT95826B publication Critical patent/PT95826B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
PT95826A 1989-11-09 1990-11-08 Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico PT95826B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3937323 1989-11-09

Publications (2)

Publication Number Publication Date
PT95826A true PT95826A (pt) 1991-09-13
PT95826B PT95826B (pt) 1997-11-28

Family

ID=6393200

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95826A PT95826B (pt) 1989-11-09 1990-11-08 Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico

Country Status (10)

Country Link
US (2) US5728735A (pt)
EP (2) EP0427247B1 (pt)
JP (1) JPH03169813A (pt)
AT (1) ATE163849T1 (pt)
CA (1) CA2029596C (pt)
DE (2) DE4035442B4 (pt)
DK (1) DK0427247T3 (pt)
ES (1) ES2115589T3 (pt)
IE (1) IE904034A1 (pt)
PT (1) PT95826B (pt)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653997B1 (fr) * 1989-11-09 1995-01-20 Asta Pharma Ag Medicaments contenant comme sunstances actives des acides carboxyliques soufres, leur preparation et leur utilisation pour lutter contre les retrovirus.
EP0560092B1 (de) * 1992-03-11 1997-12-03 ASTA Medica Aktiengesellschaft Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE9213914U1 (pt) * 1992-10-15 1992-12-03 Asta Medica Ag, 6000 Frankfurt, De
DE4235912C2 (de) * 1992-10-23 2002-12-05 Viatris Gmbh Verfahren zur Herstellung kristalliner Thioctsäure und deren Verwendung
DE4317646A1 (de) * 1993-05-27 1994-12-01 Asta Medica Ag Tabletten mit Thioctsäure und mindestens einer basischen Komponente
DE4327462A1 (de) * 1993-08-16 1995-02-23 Carl Heinrich Dr Weischer Neue N-Acetyl-p-Aminophenol-Derivate zur Bekämpfung von Schmerzzuständen
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
DE4427079C2 (de) 1994-07-30 2002-12-19 Viatris Gmbh Verfahren zur Racemisierung von Enantiomeren der alpha-Liponsäure
DE4433764A1 (de) 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
DE4439480C1 (de) * 1994-11-08 1996-06-05 Asta Medica Ag Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate
DE19510130C1 (de) * 1995-03-21 1996-11-21 Asta Medica Ag Verfahren zur Herstellung rieselfähiger R,S-Thioctsäure, R,S-Thioctsäure sowie deren Verwendung
DE19533882A1 (de) 1995-09-13 1997-03-20 Dresden Arzneimittel Herstellung und Verwendung der reinen Enantiomere der 8-Halogen-6-hydroxyoctansäuren, ihrer Alkylester und ihrer Salze mit reinen Enantiomeren des alpha-Methylbenzylamins
US7438896B2 (en) * 1995-09-20 2008-10-21 N.V. Perricone Llc Method of skin care using lipoic and ascorbic acids
DE19601787C1 (de) * 1996-01-19 1997-07-24 Asta Medica Ag Herstellung und Verwendung von Salzen der 6,8-Bis(amidiniumthio)-octansäure
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
US6365623B1 (en) 1997-11-17 2002-04-02 Nicholas V. Perricone Treatment of acne using lipoic acid
DE19806354B4 (de) * 1998-02-10 2004-09-16 Bdd Group Holding Ag Verwendung von α-Liponsäure oder deren physiologisch verträgliche Salze zur Behandlung von LDL-Hypercholesterinämie
DE19810336A1 (de) * 1998-03-11 1999-09-23 Asta Medica Ag Alpha-Liponsäure mit neuartiger Modifikation
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
WO2000010408A1 (en) * 1998-08-21 2000-03-02 Muscletech Research And Development Inc. Food supplements comprising lipoic acid and creatine and methods for their use
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
DE19941217A1 (de) * 1999-08-30 2001-03-15 Asta Medica Ag Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
WO2001021208A1 (en) * 1999-09-23 2001-03-29 Juvenon Corporation Nutritional supplement for increased energy and stamina
US6562869B1 (en) * 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
DE19954321A1 (de) * 1999-11-11 2001-07-26 Asta Medica Ag Erleichterte Verabreichung von alpha-Liponsäure oder Derivaten derselben
ES2259034T3 (es) * 2000-06-06 2006-09-16 Basf Aktiengesellschaft Uso de un enantiomero del acido lipoico en cosmeticos y dermatologicos.
EP1172110A3 (de) * 2000-07-07 2003-09-17 Basf Aktiengesellschaft Verwendung von Liponsäure zur Verbesserung der Bioverfügbarkeit von Mineralsalzen
DE10036516A1 (de) 2000-07-27 2002-02-07 Asta Medica Ag Verfahren zur Herstellung von enantiomerenreinen 6,8-Dihydroxyoctansäureestern durch assymetrische katalytische Hydrierung
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8592479B2 (en) 2000-10-31 2013-11-26 Hill's Pet Nutrition, Inc. Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
ES2266299T3 (es) 2000-11-30 2007-03-01 Basf Aktiengesellschaft Procedimiento para la obtencion acido lipoico y de acido dihidrolipoico.
ES2324400T3 (es) * 2001-02-11 2009-08-06 Aquanova Ag Procedimiento para la produccion de un concentrado de isoflavonas.
DE10111048A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von alpha-Liponsäure zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Regeneration beanspruchter Haut, insbesondere der gealterten Haut
DE10125882B4 (de) * 2001-05-28 2007-03-29 Esparma Gmbh Arzneimittel enthaltend Ambroxol, dessen Salze und/oder Prodrugs zusammen mit α-Liponsäure im Rahmen der Behandlung des Diabetes mellitus
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
DE10137381A1 (de) 2001-07-31 2003-02-13 Viatris Gmbh Neue Modifikationen des Trometamolsalzes der R-Thioctsäure sowie Verfahren zu ihrer Herstellung
US6759061B2 (en) * 2001-08-31 2004-07-06 Renew Life, Inc. Liver function improvement formulation
DE10159245A1 (de) * 2001-12-03 2003-06-18 Degussa Stabile, saure, wässrige Lösung enthaltend alpha-Liponsäure(-Derivate), Verfahren zu deren Herstellung sowie ihre Verwendung
WO2003084532A1 (en) * 2002-04-03 2003-10-16 Avery Mitchell A Lipoic acid analogs useful as provitamins and antioxidants
DE10223882A1 (de) * 2002-05-29 2003-12-18 Degussa Fliessfähige, pulverförmige Liponsäure(-Derivate) enthaltende Zusammensetzung
DE10229995A1 (de) * 2002-07-03 2004-01-15 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Liponsäure
US6787163B2 (en) * 2003-01-21 2004-09-07 Dennis H. Harris Therapeutic treatment for blood sugar regulation
KR20040097820A (ko) * 2003-05-13 2004-11-18 이기업 알파 리포산을 유효성분으로 함유하는 천식 예방 및치료용 조성물
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
US20100112088A1 (en) * 2003-08-29 2010-05-06 Jay Pravda Materials and methods for treatment of disorders associated with oxidative stress
US20050192229A1 (en) * 2004-02-27 2005-09-01 Perricone Nicholas V. Topical glutathione treatments
CN100422134C (zh) * 2004-03-12 2008-10-01 北京天衡药物研究院 新的2-（α-正戊酮基）苯甲酸盐及其制法和用途
JP4849792B2 (ja) * 2004-09-14 2012-01-11 オリザ油化株式会社 美容用組成物
JP2006129841A (ja) * 2004-11-09 2006-05-25 Nof Corp α−リポ酸含有水性組成物
CA2588709C (en) * 2004-11-24 2015-07-14 Hill's Pet Nutrition, Inc. Use of lipoic acid to improve hepatic clearance of xenobiotic substances
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
DE102004060914A1 (de) * 2004-12-17 2006-07-06 Bioghurt Biogarde Gmbh & Co. Kg Verwendung von Liponsäure-haltigen Cyclodextrin-Komplexen
CN104304671A (zh) 2004-12-29 2015-01-28 希尔氏宠物营养品公司 抑制动物学习和/或记忆减退的方法
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
CA2592844C (en) * 2004-12-30 2012-10-09 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP2006219467A (ja) * 2005-02-10 2006-08-24 Oriza Yuka Kk 脂肪蓄積阻害剤
JP2007016000A (ja) * 2005-07-11 2007-01-25 Taiyo Kagaku Co Ltd チオクト酸含有組成物
US8722112B2 (en) 2005-07-14 2014-05-13 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
SI1754478T1 (sl) 2005-08-04 2009-06-30 Encrypta Gmbh Tekoč sestavek, ki obsega arginin in alfa-lipojsko kislino, in njegova uporaba za izboljšanje seksualne funkcije
KR100705199B1 (ko) 2005-09-02 2007-04-06 부광약품 주식회사 Ｄ-(+)-α-리포산 트로메타민염을 포함하는 간섬유화 억제 및 치료용 조성물
US20070082064A1 (en) * 2005-10-12 2007-04-12 Krawitz Paul L Nutritional or dietary supplement for the treatment of macular degeneration
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
NZ581710A (en) * 2007-06-13 2012-02-24 Jay Pravda Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
CN101352435B (zh) * 2007-07-25 2011-05-18 中国科学院上海生命科学研究院 硫辛酰胺在制备防治老年性视网膜黄斑变性的制剂中的应用
WO2010047793A2 (en) 2008-10-21 2010-04-29 The General Hospital Corporation Cell transplantation
WO2010047717A1 (en) * 2008-10-24 2010-04-29 Biolink Life Sciences, Inc. Stable, water-insoluble r-(+)-alpha-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities
US7928067B2 (en) * 2009-05-14 2011-04-19 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
KR100935554B1 (ko) * 2009-06-24 2010-01-07 주식회사 셀트리온제약 피페라진 다이티옥트산염 및 이를 포함하는 약제학적 조성물
IT1398281B1 (it) * 2009-07-30 2013-02-22 Difass S A Ora Farmapros S P A Composizione comprendente acido alfa-lipoico e carnosina per il trattamento della sindrome cpps, della sindrome cp e/o della vulvodinia
US20110237658A1 (en) * 2010-03-23 2011-09-29 Krishani Biosciences (P) Ltd Compound and method for the treatment of pain
IT1399923B1 (it) 2010-05-11 2013-05-09 Cbb Net S A Procedimento di preparazione di sali dell'acido (r) alfa-lipoico loro formulazione ed uso nelle composizioni farmaceutiche in forma di compresse che li contengono
EP2389931A1 (en) * 2010-05-21 2011-11-30 Raw Materials Internatinal LLC Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
WO2012014746A1 (ja) * 2010-07-30 2012-02-02 株式会社シクロケム αリポ酸複合体
EP2601299B1 (en) 2010-08-06 2019-04-24 The General Hospital Corporation D/B/A Massachusetts General Hospital System and apparatus for cell treatment
RU2605330C2 (ru) * 2010-10-27 2016-12-20 Нестек С.А. Способы и композиции, подходящие для укрепления здоровья кожи
SG190794A1 (en) 2010-11-18 2013-07-31 Ischemix Llc Lipoyl compounds and their use for treating ischemic injury
US9421234B2 (en) * 2011-05-20 2016-08-23 Nutramax Laboratories, Inc. Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration
ITMI20111452A1 (it) * 2011-07-29 2013-01-30 Istituto Biochimico Naz Sav Io Srl Soluzione basica di acido alfa-lipoico e suoi usi
US20160235709A1 (en) 2012-08-31 2016-08-18 Molecular product management LLC Limited release lingual thioctic acid delivery systems
WO2013033662A1 (en) 2011-08-31 2013-03-07 Zolentroff, William, C. Limited release lingual thioctic acid delivery systems
WO2013115740A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Synergisctic combination comprising a meglitinide derivative and lipoic acid
ES2622372T3 (es) 2012-11-09 2017-07-06 Scidose Llc Composición de enema para tratamiento de la colitis ulcerosa que tiene estabilidad a largo plazo
US9457011B2 (en) * 2014-02-25 2016-10-04 Muslim D. Shahid Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor
WO2016138569A1 (en) * 2015-03-04 2016-09-09 The University Of Queensland Method of treatment of central neuropathic pain
WO2018064238A1 (en) 2016-09-27 2018-04-05 Zolentroff William C Ala and salt formulation
US10744115B2 (en) 2017-04-25 2020-08-18 Ischemix Llc Compositions and methods for treating traumatic brain injury
WO2019153099A1 (es) * 2018-02-12 2019-08-15 Gador Limitada Compuesto y procedimiento para optimizar el trasplante de los órganos sólidos vascularizados y reducir la disfunción de los mismos
IT202000009577A1 (it) 2020-04-30 2021-10-30 Fatro Spa Formulazioni iniettabili di acido lipoico per il trattamento dello stress ossidativo e delle alterazioni metaboliche
CA3226564A1 (en) * 2021-09-09 2023-03-16 Biora Therapeutics, Inc. Aqueous formulations of tofacitinib and tofacitinib salts

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6439M (pt) * 1967-05-19 1968-11-04
FR6518M (pt) * 1967-05-19 1968-12-09
DE1668887B2 (de) * 1968-03-15 1976-06-16 Ca-salz der 1,2 -dithia-cyclopentan - 3- valerian saeure gleich (thioctsaeure)
US3577551A (en) * 1968-04-20 1971-05-04 Yamanouchi Pharma Co Ltd Methods for treating pain,inflammation and cough
SU620266A1 (ru) * 1977-02-16 1978-07-06 Предприятие П/Я В-2343 Автономный респиратор с поддувом
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
EP0159519A3 (de) * 1984-03-29 1987-02-04 Asta-Werke Aktiengesellschaft Chemische Fabrik Verwendung von Thioverbindungen zur Verhinderung des durch Cytostatika verursachten Haarausfalls
DE3512911A1 (de) * 1985-04-11 1986-10-16 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von 1,2-dithiolan-3-pentansaeure (thioctsaeure)
DE3629116A1 (de) * 1986-08-27 1988-03-10 Asta Pharma Ag Verfahren zur herstellung enantiomerenreiner r-(+)-(alpha)-liponsaeure und s-(-)-(alpha)-liponsaeure (thioctsaeure) sowie nonen- beziehungsweise mesylderivate als zwischenprodukte hierfuer
DE3840076A1 (de) * 1987-12-04 1989-06-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren
ATE70974T1 (de) * 1987-12-04 1992-01-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
JPH07103457B2 (ja) 1989-02-10 1995-11-08 トミー株式会社 形状記憶合金製矯正ワイヤーの形態付与方法

Also Published As

Publication number Publication date
ES2115589T3 (es) 1998-07-01
DE4035442A1 (de) 1991-05-16
EP0427247B1 (de) 1998-03-11
IE904034A1 (en) 1991-05-22
PT95826B (pt) 1997-11-28
ATE163849T1 (de) 1998-03-15
DE4035442B4 (de) 2010-04-29
US6271254B1 (en) 2001-08-07
US5728735A (en) 1998-03-17
EP0812590A3 (de) 1999-06-09
DK0427247T3 (da) 1998-09-28
CA2029596C (en) 2000-05-23
CA2029596A1 (en) 1991-05-10
EP0427247A2 (de) 1991-05-15
JPH03169813A (ja) 1991-07-23
EP0812590A2 (de) 1997-12-17
EP0427247A3 (en) 1992-01-02
DE59010810D1 (de) 1998-04-16

Similar Documents

Publication Publication Date Title
PT95826A (pt) Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
PT91246A (pt) Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo
HUT43843A (en) Process for production of derivatives of benzimidasole and medical compounds containing thereof
ES2087916T3 (es) Derivado de pirimidina biciclico, metodo para producir el mismo, y preparacion farmaceutica que contiene el mismo como ingrediente activo.
DK0509317T3 (da) Lægemidler imod knoglesygdomme
ES2113413T3 (es) Derivados antiviricos del acido 2-desoxi-2,3-didehidro alfa-d-neuraminico 4 substituido.
MX9100160A (es) Procedimiento para preparar un medicamento que contiene flupirtina como sustancia activa para combatir contracturas musculares
ATE188119T1 (de) Heilmittel für wunden und hämorrhoiden
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
PT89534A (pt) Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina
MX9300875A (es) Procedimiento para la preparacion de compuestos azabiciclicos.
SE8705150D0 (sv) Novel antiarrhythmic agents
PT90034A (pt) Processo para a preparacao de tetra-hidroimidazo-{1,4}benzodiazepina-2-onas
PT84564B (pt) Processo para a preparacao de derivados de acidos dicarboxilicos diazotados substituidos com actividade nootropica
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
PT81246B (pt) Processo para a preparacao de pirazolo-piridino-amidas e dos seus derivados 7-n-oxidos e de composicoes farmaceuticas contendo estes compostos
PT94034A (pt) Processo para a preparacao de eteres (tio) morfolinilo e piperazinilo-alquilfenolico anti-rinovirais
PT87737A (pt) Processo para a preparacao de composicoes farmaceuticas analgesicas contendo derivados de dioxopiperidina como substancia activa
DK429480A (da) Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel
MX13723A (es) Procedimiento para preparar derivados de 9-desoxo-9a-alil- y propargil-9a-aza-9a-homoeritromicina a
PT95810A (pt) Processo para a preparacao de composicoes farmaceuticas injectaveis contendo um alcaloide de bis-indol como ingrediente activo
ATE18203T1 (de) (-)-15-deoxyspergualin, seine herstellung und arzneimittel mit diesem wirkstoff.
NO873934L (no) Saarhelende serotoninantagonistisk forbindelse.
HUT47020A (en) Process for production of stabilly injectable medical compounds containing as active substance 1,4-dihidroxi-5,8-bis/2/2-hidroxi-ethil-amin/-ethil-amin-antraquinon-dihydrochlorid

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910403

FG3A Patent granted, date of granting

Effective date: 19970902

PC3A Transfer or assignment

Free format text: ASTA MEDICA HEALTH PRODUCTS GMBH & CO. KG DE

Effective date: 20020909

PD3A Change of proprietorship

Free format text: VIATRIS GMBH & CO. KG DE

Effective date: 20020909

Free format text: ASTA MEDICA GMBH DE

Effective date: 20020909

TE3A Change of address (patent)

Free format text: ASTA MEDICA AKTIENGESELLSCHAFT DE

Effective date: 20020909

TE3A Change of address (patent)

Free format text: VIATRIS GMBH & CO. KG DE

Effective date: 20050506

PC4A Transfer of assignment

Owner name: EVONIK DEGUSSA GMBH, DE

Effective date: 20081027

PD4A Change of proprietorship

Owner name: MEDA PHARMA GMBH & CO. KG, DE

Effective date: 20081015

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120903